For more VICC news, visit their website »
An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
Measuring levels of an enzyme in head and neck tumors may indicate how the tumor will respond to radiation therapy.
Cellular pathways altered by chronic exposure to cigarette smoke may reveal new biomarkers to assess smoking-induced lung cancer risk.